DocuSign, Inc. (NASDAQ:DOCU) Shares Acquired by Mediolanum International Funds Ltd

Mediolanum International Funds Ltd boosted its holdings in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 25.4% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 158,993 shares of the company's stock after buying an additional 32,245 shares during the quarter. Mediolanum International Funds Ltd owned 0.08% of DocuSign worth $14,544,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in DOCU. Avior Wealth Management LLC raised its position in DocuSign by 36.5% in the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company's stock worth $49,000 after acquiring an additional 145 shares during the period. Linden Thomas Advisory Services LLC raised its holdings in DocuSign by 1.1% in the 4th quarter. Linden Thomas Advisory Services LLC now owns 13,540 shares of the company's stock worth $1,218,000 after purchasing an additional 149 shares during the period. J.W. Cole Advisors Inc. grew its holdings in DocuSign by 2.0% during the third quarter. J.W. Cole Advisors Inc. now owns 7,946 shares of the company's stock valued at $493,000 after purchasing an additional 155 shares during the period. Resonant Capital Advisors LLC grew its holdings in DocuSign by 0.9% during the third quarter. Resonant Capital Advisors LLC now owns 17,516 shares of the company's stock valued at $1,088,000 after purchasing an additional 157 shares during the period. Finally, Optimist Retirement Group LLC increased its position in DocuSign by 3.8% in the third quarter. Optimist Retirement Group LLC now owns 4,416 shares of the company's stock worth $274,000 after buying an additional 161 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company's stock.

DocuSign Stock Down 0.2 %

DOCU traded down $0.23 during trading hours on Monday, reaching $96.50. 2,719,058 shares of the company's stock traded hands, compared to its average volume of 2,158,718. The firm has a 50-day moving average price of $91.32 and a 200 day moving average price of $73.08. The firm has a market capitalization of $19.50 billion, a PE ratio of 19.90, a PEG ratio of 8.74 and a beta of 0.88. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86.

Insider Activity at DocuSign

In other DocuSign news, insider Robert Chatwani sold 14,800 shares of the company's stock in a transaction on Wednesday, December 18th. The stock was sold at an average price of $97.76, for a total transaction of $1,446,848.00. Following the completion of the sale, the insider now owns 73,414 shares in the company, valued at $7,176,952.64. This represents a 16.78 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Teresa Briggs sold 534 shares of the company's stock in a transaction on Monday, December 16th. The stock was sold at an average price of $94.60, for a total value of $50,516.40. Following the sale, the director now owns 7,736 shares of the company's stock, valued at $731,825.60. This trade represents a 6.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 685,773 shares of company stock worth $66,032,726 in the last 90 days. 1.66% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on DOCU shares. Jefferies Financial Group increased their target price on shares of DocuSign from $80.00 to $95.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. Royal Bank of Canada restated a "sector perform" rating and set a $90.00 price objective (up from $57.00) on shares of DocuSign in a research report on Friday, December 6th. Wells Fargo & Company increased their price target on DocuSign from $50.00 to $70.00 and gave the stock an "underweight" rating in a research note on Friday, December 6th. HSBC reissued a "reduce" rating on shares of DocuSign in a report on Friday, December 6th. Finally, Morgan Stanley raised their target price on shares of DocuSign from $62.00 to $97.00 and gave the company an "equal weight" rating in a research note on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, DocuSign presently has a consensus rating of "Hold" and a consensus price target of $92.45.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.